D.E. Shaw & Co’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

D.E. Shaw & Co’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-42,000	Closed	-$712K	–	4343
2014 Q4	$712K	Sell	42,000 -673,713	-94%	-$9.48M	﹤0.01%	3078
2014 Q3	$8.53M	Buy	715,713 +684,813	+2,216%	+$4.68M	0.01%	1186
2014 Q2	$174K	Buy	30,900 +8,254	+36%	+$38K	﹤0.01%	4020
2014 Q1	$83K	Sell	22,646 -76,891	-77%	-$293K	﹤0.01%	4183
2013 Q4	$334K	Buy	+99,537	New	+$411K	﹤0.01%	3994

D.E. Shaw & Co's AVNR Position: Q1 2015 in Review

D.E. Shaw & Co sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 42,000 shares — an estimated $712K sold.

D.E. Shaw & Co first reported a position in AVNR in Q4 2013 and held it in 5 quarters. The position peaked at $8.53M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

D.E. Shaw & Co reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
D.E. Shaw & Co sold 42,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $712K.
D.E. Shaw & Co first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2013 and held it in 5 quarters.
D.E. Shaw & Co's AVANIR PHARMACEUTICALS, INC CL A position peaked at $8.53M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.